Metabolomic age acceleration

Biomarker

1 paper4 findings

  • Humans1

Associations

4

Risk of a higher frailty score

upin humans1

1 study
  1. Metabolomic age acceleration is associated with risk of a higher frailty score in humans (10% increased risk per standard deviation (∼5 years)).

    “10% increased risk of a higher frailty score in fully adjusted models.”

    Humansfully adjusted modelsEach standard deviation higher metabolomic age acceleration (∼5 years)

    Assessment of ageing using global mass-spectrometry based metabolomics: A cross-cohort longitudinal study in the UK and Ireland

    medRxiv10 Feb 2026Preprint

Mild cognitive impairment

upin humans1

1 study
  1. Metabolomic age acceleration is associated with mild cognitive impairment in humans (27% higher risk per standard deviation (∼5 years)).

    “Each standard deviation higher metabolomic age acceleration (∼5 years) was associated with 43% higher mortality risk, 27% higher risk of mild cognitive impairment”

    Humansfully adjusted modelsEach standard deviation higher metabolomic age acceleration (∼5 years)

    Assessment of ageing using global mass-spectrometry based metabolomics: A cross-cohort longitudinal study in the UK and Ireland

    medRxiv10 Feb 2026Preprint

More on Mild cognitive impairment

Mortality

upin humans1

1 study
  1. Metabolomic age acceleration is associated with mortality in humans (43% higher mortality risk per standard deviation (∼5 years)).

    “Each standard deviation higher metabolomic age acceleration (∼5 years) was associated with 43% higher mortality risk”

    Humansfully adjusted modelsEach standard deviation higher metabolomic age acceleration (∼5 years)

    Assessment of ageing using global mass-spectrometry based metabolomics: A cross-cohort longitudinal study in the UK and Ireland

    medRxiv10 Feb 2026Preprint

Metabolomic age acceleration at another study visit

upin humans1

1 study
  1. Metabolomic age acceleration is associated with metabolomic age acceleration at another study visit in humans (r > 0.6).

    “Metabolomic age acceleration was strongly correlated between study visits ( r > 0.6).”

    Humansbetween study visits

    Assessment of ageing using global mass-spectrometry based metabolomics: A cross-cohort longitudinal study in the UK and Ireland

    medRxiv10 Feb 2026Preprint

More on Metabolomic age acceleration at another study visit

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months